cro.directory
← Compare landing

BioDuro-Sundia vs Frontage Laboratories

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/bioduro-sundia/frontagelab

CategoryBioDuro-SundiaFrontage Laboratories
Listed sitecrocro
SummaryBioDuro-Sundia is a contract research, development, and manufacturing organization (CRDMO) with 30 years of expertise providing integrated drug discovery, development, and manufacturing services from target identification through IND submission.Global pharmaceutical development organization offering integrated drug discovery, preclinical safety/toxicology, DMPK, bioanalytical, and clinical trial services across 28 sites with 2,200 employees and 200+ FDA inspections.
Services
  • Discovery Research
  • Target Identification & Validation
  • High-Throughput Screening
  • Computational & In-Silico Drug Discovery
  • Medicinal Chemistry
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Safety Pharmacology
  • Genetic Toxicology
  • Preclinical In Vitro Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • GLP Toxicology
  • Specialized & Large-Animal Models
  • Preclinical In Vivo Studies
  • Bioanalysis
  • Biomarker Assays
  • Flow Cytometry Services
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Translational Research
  • US FDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Regulatory Affairs
  • Immunogenicity Assays (ADA / NAb)
  • Oncology Specialty Services
  • Immunology & Inflammation Services
  • Medicinal Chemistry
  • Computational & In-Silico Drug Discovery
  • In Vitro ADME / DMPK
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • Safety Pharmacology
  • Genetic Toxicology
  • DART (Reproductive & Developmental Toxicology)
  • GLP Toxicology
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Clinical Operations
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Flow Cytometry Services
  • Central Laboratory Services
  • Pathology & Histology Services
  • Genomics & Sequencing Services
  • Biostatistics & Statistical Programming
  • Data Management & eClinical
  • Medical Writing
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Discovery Research
  • Target Identification & Validation
  • High-Throughput Screening
  • Specialized & Large-Animal Models
  • Phase III Clinical Trials
  • Clinical Trial Services
  • Regulatory Affairs
  • US FDA Regulatory Strategy
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Peptide
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Antibody-Drug Conjugate (ADC)
  • Cell Therapy
  • Gene Therapy
Indications
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Respiratory
  • Oncology
Locations
  • Headquarters, Irvine, California, United States
  • Headquarters
  • Global Operations
CertificationsData not yet provided.
  • FDA · Identifier: 200+ FDA Inspections
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.